ID	Title	Short name	Biological organization
3	"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"	"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"	Cellular
8	"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"	"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"	Cellular
9	"Activation, 5HT2c"	"Activation, 5HT2c"	Molecular
10	"Accumulation, Acetylcholine in synapses"	"Accumulation, Acetylcholine in synapses"	Cellular
12	"Inhibition, Acetylcholinesterase (AchE)"	"Inhibition, Acetylcholinesterase (AchE)"	Cellular
17	"Altered regulation, AHR nuclear translocator (ARNT)-dependent pathways"	"Altered regulation, AHR nuclear translocator (ARNT)-dependent pathways"	Molecular
18	"Activation, AHR"	"Activation, AHR"	Molecular
21	"Altered regulation, Alpha hemoglobin"	"Altered regulation, Alpha hemoglobin"	Cellular
25	"Agonism, Androgen receptor"	"Agonism, Androgen receptor"	Molecular
26	"Antagonism, Androgen receptor"	"Antagonism, Androgen receptor"	Molecular
27	"N/A, Androgen receptor, Antagonism"	"N/A, Androgen receptor, Antagonism"	Molecular
28	"Reduction, Angiogenic sprouting"	"Reduction, Angiogenic sprouting"	Molecular
29	"Reduction in, Angiogenic sprouts"	"Reduction in, Angiogenic sprouts"	
35	"Decrease, Aromatase (Cyp19a1)"	"Decrease, Aromatase (Cyp19a1)"	Cellular
36	"Inhibition, Aromatase"	"Inhibition, Aromatase"	Molecular
39	"Induction, Ataxia, paralysis, or hyperactivity"	"Induction, Ataxia, paralysis, or hyperactivity"	Organ
40	"Decreased, ATP production"	"Decreased, ATP production"	Cellular
41	"Inhibition, Bile Salt Export Pump (ABCB11)"	"Inhibition, Bile Salt Export Pump (ABCB11)"	Molecular
42	"Up Regulation, Biliary excretion"	"Up Regulation, Biliary excretion"	
46	"Accumulation, Biological membranes"	"Accumulation, Biological membranes"	Cellular
49	"Reduction, Ca and HCO3 transport to shell gland"	"Reduction, Ca and HCO3 transport to shell gland"	Tissue
50	"Increase, Ca++ (intracellular)"	"Increase, Ca++ (intracellular)"	Cellular
51	"Inhibition, Ca++ ATPase"	"Inhibition, Ca++ ATPase"	Molecular
52	"Decreased, Calcium influx"	"Decreased, Calcium influx"	Cellular
54	"Up Regulation, CD36"	"Up Regulation, CD36"	Molecular
55	"N/A, Cell injury/death"	"N/A, Cell injury/death"	Cellular
57	"Proliferation, Cell proliferation in the absence of cytotoxicity"	"Proliferation, Cell proliferation in the absence of cytotoxicity"	Cellular
59	"Inhibition of Apoptosis in Altered Hepatic Foci, Changes in Cellular Growth Homeostasis"	"Inhibition of Apoptosis in Altered Hepatic Foci, Changes in Cellular Growth Homeostasis"	
60	"Induction, Chitin degradation and resorption"	"Induction, Chitin degradation and resorption"	
62	"Induction, Chitin synthesis"	"Induction, Chitin synthesis"	
64	"Reduction, Ionotropic GABA receptor chloride channel conductance"	"Reduction, Ionotropic GABA receptor chloride channel conductance"	Cellular
66	"Activation, ChREBP"	"Activation, ChREBP"	Molecular
68	"Accumulation, Collagen"	"Accumulation, Collagen"	Tissue
71	"Activation, Constitutive androstane receptor, NR1l3"	"Activation, Constitutive androstane receptor, NR1l3"	
75	"N/A, Covalent binding to protein, possibly lysine residue"	"N/A, Covalent binding to protein, possibly lysine residue"	Molecular
77	"Production, Critical Metabolites (CGA 330050 and CGA 265307)"	"Production, Critical Metabolites (CGA 330050 and CGA 265307)"	Cellular
78	"Reduction, Cumulative fecundity and spawning"	"Reduction, Cumulative fecundity and spawning"	Individual
79	"Inhibition, Cyclooxygenase activity"	"Inhibition, Cyclooxygenase activity"	Molecular
80	"Up Regulation, CYP1A1"	"Up Regulation, CYP1A1"	Molecular
84	"Up Regulation, CYP1B1"	"Up Regulation, CYP1B1"	Molecular
87	"Release, Cytokine"	"Release, Cytokine"	Cellular
89	"Synthesis, De Novo FA"	"Synthesis, De Novo FA"	Cellular
97	"Alkylation, DNA"	"Alkylation, DNA"	Molecular
103	"Activation, Ecdysone receptor"	"Activation, EcR"	Molecular
105	"Inhibition, ECT complexes of the respiratory chain"	"Inhibition, ECT complexes of the respiratory chain"	
106	"Reduction, Eggshell thickness"	"Reduction, Eggshell thickness"	Tissue
110	"Impairment, Endothelial network"	"Impairment, Endothelial network"	Molecular
111	"Agonism, Estrogen receptor"	"Agonism, Estrogen receptor"	Molecular
112	"Antagonism, Estrogen receptor"	"Antagonism, Estrogen receptor"	Molecular
115	"Increase, FA Influx"	"Increase, FA Influx"	Cellular
116	"Activation, FAS"	"Activation, FAS"	Molecular
118	"Formation, Formation of hemoglobin adducts"	"Formation, Formation of hemoglobin adducts"	Cellular
119	"N/A, Gap"	"N/A, Gap"	Tissue
122	"Activation, Glucocorticoid Receptor"	"Activation, Glucocorticoid Receptor"	Molecular
129	"Reduction, Gonadotropins, circulating concentrations"	"Reduction, Gonadotropins, circulating concentrations"	Organ
130	"Depletion, GSH"	"Depletion, GSH"	Cellular
131	"Down Regulation, Gulcose-6-phosphate dehydrogenase"	"Down Regulation, Gulcose-6-phosphate dehydrogenase"	Cellular
134	"Increased, Activation and Recruitment of Hepatic macrophages (Kupffer Cells)"	"Increased, Activation and Recruitment of Hepatic macrophages (Kupffer Cells)"	Cellular
135	"Increase, Hepatic transport of parent T4"	"Increase, Hepatic transport of parent T4"	
136	"Up Regulation, Hepatic transporter gene expression"	"Up Regulation, Hepatic transporter gene expression"	
139	"N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects"	"N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects"	Tissue
140	"Decreased, HSD17B10 expression"	"Decreased, HSD17B10 expression"	Cellular
142	"Hyperplasia, Hyperplasia"	"Hyperplasia, Hyperplasia"	Tissue
145	"Induction, IKB inhibitory protein"	"Induction, IKB inhibitory protein"	Cellular
147	"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307"	"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307"	Cellular
149	"Increase, Inflammation"	"Increase, Inflammation"	Cellular
151	"Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways"	"Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways"	Molecular
152	"Suppression, Inflammatory cytokines"	"Suppression, Inflammatory cytokines"	Individual
155	"N/A, Insufficient or incorrect DNA repair"	"N/A, Insufficient or incorrect DNA repair"	Cellular
158	"N/A, Interferences with SH-/selen-proteins"	"N/A, Interferences with SH-/selen-proteins"	Cellular
161	"Increase, Liver and splenic hemosiderosis"	"Increase, Liver and splenic hemosiderosis"	Organ
164	"Induction, Liver “Dysfunctional” Changes by CGA 330050"	"Induction, Liver “Dysfunctional” Changes by CGA 330050"	Organ
165	"Activation, Long term AHR receptor driven direct and indirect gene expression changes"	"Activation, Long term AHR receptor driven direct and indirect gene expression changes"	Cellular
166	"Decreased, Long-term potentiation (LTP)"	"Decreased, Long-term potentiation (LTP)"	Organ
167	"Activation, LXR"	"Activation, LXR"	Molecular
168	"Decreased, Lymphocytes"	"Decreased, Lymphocytes"	Individual
169	"Disruption, Membrane integrity"	"Disruption, Membrane integrity"	Cellular
173	"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number"	"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number"	Organ
176	"Damaging, Mitochondria"	"Damaging, Mitochondria"	Cellular
177	"N/A, Mitochondrial dysfunction 1"	"N/A, Mitochondrial dysfunction 1"	Cellular
178	"Disruption, Mitochondrial electron transport chain"	"Disruption, Mitochondrial electron transport chain"	Cellular
179	"Decreased, Mitochondrial fatty acid beta-oxidation"	"Decreased, Mitochondrial fatty acid beta-oxidation"	Molecular
183	"Abnormal, Morphogenesis"	"Abnormal, Morphogenesis"	
185	"Increase, Mutations"	"Increase, Mutations"	Molecular
186	"Altered, Neuroanatomy"	"Altered, Neuroanatomy"	Organ
188	"N/A, Neuroinflammation"	"N/A, Neuroinflammation"	Tissue
191	"N/A, Neuronal dysfunction"	"N/A, Neuronal dysfunction"	Cellular
192	"Altered, Neurophysiology"	"Altered, Neurophysiology"	Organ
193	"Decreased, Nitric Oxide"	"Decreased, Nitric Oxide"	Cellular
195	"Inhibition, NMDARs"	"Inhibition, NMDARs"	Molecular
201	"Binding of antagonist, NMDA receptors"	"Binding of antagonist, NMDA receptors"	Molecular
202	"Inhibition, Nuclear factor kappa B (NF-kB)"	"Inhibition, Nuclear factor kappa B (NF-kB)"	Molecular
209	"Increase, Oxidative Stress"	"Increase, Oxidative Stress"	Cellular
210	"N/A, Oxidative stress"	"N/A, Oxidative stress"	Cellular
211	"Propagation, Oxidative stress"	"Propagation, Oxidative stress"	Molecular
213	"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)"	"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leadin"	Molecular
214	"Bile accumulation, Pathological condition"	"Bile accumulation, Pathological condition"	Cellular
216	"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"	"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"	Cellular
219	"Reduction, Plasma 17beta-estradiol concentrations"	"Reduction, Plasma 17beta-estradiol concentrations"	Individual
220	"Increase, Plasma vitellogenin concentrations"	"Increase, Plasma vitellogenin concentrations"	Organ
221	"Reduction, Plasma vitellogenin concentrations"	"Reduction, Plasma vitellogenin concentrations"	Organ
222	"Elimination of (high doses), Posterior cardinal vein"	"Elimination of (high doses), Posterior cardinal vein"	
227	"Activation, PPAR?"	"Activation, PPAR?"	Molecular
228	"Activation, PPAR?"	"Activation, PPAR?"	Molecular
231	"Decreased, PPAR-alpha activation"	"Decreased, PPAR-alpha activation"	Molecular
232	"Decreased, PPAR-beta activation"	"Decreased, PPAR-beta activation"	Molecular
233	"Decreased, PPAR-gamma activation"	"Decreased, PPAR-gamma activation"	Molecular
234	"Activation, PPAR? & PPAR?"	"Activation, PPAR? & PPAR?"	Molecular
238	"Induction, Pre-mature molting"	"Induction, Pre-mature molting"	
239	"Activation, Pregnane-X receptor, NR1l2"	"Activation, Pregnane-X receptor, NR1l2"	Molecular
240	"Feminisation or incomplete development, Primary and accessory male sex organs"	"Feminisation or incomplete development, Primary and accessory male sex organs"	Organ
243	"Reduction, Prostaglandin E2 concentration"	"Reduction, Prostaglandin E2 concentration"	Tissue
244	"Alkylation, Protein"	"Alkylation, Protein"	Molecular
245	"Activation, PXR/SXR"	"Activation, PXR/SXR"	Molecular
246	"Increase, RBC congestion in liver"	"Increase, RBC congestion in liver"	Organ
249	"Production, Reactive oxygen species"	"Production, Reactive oxygen species"	Tissue
250	"Damaging, Red blood cells; hemolysis"	"Damaging, Red blood cells; hemolysis"	Cellular
252	"Increase, Renal pathology due to VTG deposition"	"Increase, Renal pathology due to VTG deposition"	Organ
253	"N/A, Reproductive failure"	"N/A, Reproductive failure"	Individual
257	"Increased, ROS production"	"Increased, ROS production"	Cellular
258	"Activation, SCD-1"	"Activation, SCD-1"	Molecular
259	"Decrease, Serum thyroxine (T4)"	"Decrease, Serum thyroxine (T4)"	
261	"Binding, SH-/selen-proteins"	"Binding, SH-/selen-proteins"	Molecular
264	"Activation, SREBP-1c"	"Activation, SREBP-1c"	Molecular
265	"Activation, Stellate cells"	"Activation, Stellate cells"	Cellular
266	"Decrease, Steroidogenic acute regulatory protein (STAR)"	"Decrease, Steroidogenic acute regulatory protein (STAR)"	Cellular
267	"Damage, Structure of the cochlea"	"Damage, Structure of the cochlea"	
269	"Induction, Sustained Cell Proliferation"	"Induction, Sustained Cell Proliferation"	Cellular
270	"Induction, Sustained Hepatotoxicity"	"Induction, Sustained Hepatotoxicity"	Individual
272	"Activation/Proliferation, T-cells"	"Activation/Proliferation, T-cells"	Organ
274	"Reduction, Testosterone synthesis by ovarian theca cells"	"Reduction, Testosterone synthesis by ovarian theca cells"	Cellular
276	"Up Regulation, TGFbeta1 expression"	"Up Regulation, TGFbeta1 expression"	Cellular
277	"Thyroid hormone synthesis, Decreased"	"Thyroid hormone synthesis, Decreased"	Molecular
279	"Thyroperoxidase, Inhibition"	"Thyroperoxidase, Inhibition"	Molecular
280	"Thyroxine (T4) in neuronal tissue, Decreased"	"Thyroxine (T4) in neuronal tissue, Decreased"	Organ
281	"Thyroxine (T4) in serum, Decreased"	"Thyroxine (T4) in serum, Decreased"	Tissue
283	"Decrease, Tissue thyroid hormone concentration"	"Decrease, Tissue thyroid hormone concentration"	
284	"Decrease, TR-regulated cochlear proteins"	"Decrease, TR-regulated cochlear proteins"	
285	"Reduction, Vitellogenin synthesis in liver"	"Reduction, Vitellogenin synthesis in liver"	Tissue
286	"Decreased, Transcription of genes by AR"	"Decreased, Transcription of genes by AR"	Cellular
288	"Activation of specific nuclear receptors, Transcriptional change"	"Activation of specific nuclear receptors, Transcriptional change"	Cellular
289	"Decrease, Translocator protein (TSPO)"	"Decrease, Translocator protein (TSPO)"	Cellular
291	"Accumulation, Triglyceride"	"Accumulation, Triglyceride"	Cellular
294	"N/A, Unknown"	"N/A, Unknown"	Molecular
295	"Induction, Upregulation of glucuronyltransferase activity"	"Induction, Upregulation of glucuronyltransferase activity"	Molecular
298	"Insufficiency, Vascular"	"Insufficiency, Vascular"	Molecular
301	"Binding, VEGF-A"	"Binding, VEGF-A"	
302	"Production, VEGF-A"	"Production, VEGF-A"	
304	"Decreased, VegfR2"	"Decreased, VegfR2"	
305	"Inhibition, VegfR2"	"Inhibition, VegfR2"	Molecular
307	"Increase, Vitellogenin synthesis in liver"	"Increase, Vitellogenin synthesis in liver"	Tissue
309	"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"	"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"	Cellular
310	"Alteration, Wnt pathway"	"Alteration, Wnt pathway"	Cellular
312	"N/A, Allergic contact dermatitis on challenge"	"N/A, Allergic contact dermatitis on challenge"	Individual
313	"Increase, Allergic Respiratory Hypersensitivity Response"	"Increase, Allergic Respiratory Hypersensitivity Response"	Organ
315	"Decreased, Body length"	"Decreased, Body length"	
317	"Altered, Cardiovascular development/function"	"Altered, Cardiovascular development/function"	Organ
319	"Loss, Cochlear function"	"Loss, Cochlear function"	Organ
320	"Increase, Curved body axis"	"Increase, Curved body axis"	
321	"N/A, Cyanosis occurs"	"N/A, Cyanosis occurs"	Individual
323	"Increased, Disease susceptibility"	"Increased, Disease susceptibility"	Individual
325	"N/A, Embryotoxicity"	"N/A, Embryotoxicity"	Individual
327	"Accumulation, Fatty acid"	"Accumulation, Fatty acid"	Organ
328	"Reduction, Fecundity"	"Reduction, Fecundity"	
330	"Decreased, Fertility"	"Decreased, Fertility"	Individual
331	"Decreased, Fetal birth weight"	"Decreased, Fetal birth weight"	
332	"Increased, Functional deficits"	"Increased, Functional deficits"	
334	"Promotion, Hepatocelluar carcinoma"	"Promotion, Hepatocelluar carcinoma"	Individual
336	"Increase, Heritable mutations in offspring"	"Increase, Heritable mutations in offspring"	Individual
337	"N/A, Impairment of reproductive capacity"	"N/A, Impairment of reproductive capacity"	Individual
339	"Altered, Larval development"	"Altered, Larval development"	Individual
341	"Impairment, Learning and memory"	"Impairment, Learning and memory"	Individual
342	"Increased, Lethality"	"Increased, Lethality"	
344	"N/A, Liver fibrosis"	"N/A, Liver fibrosis"	Organ
345	"N/A, Liver Steatosis"	"N/A, Liver Steatosis"	Organ
346	"Undefined, Liver Steatosis"	"Undefined, Liver Steatosis"	Organ
347	"Formation, Liver tumor"	"Formation, Liver tumor"	Individual
348	"Malformation, Male reproductive tract"	"Malformation, Male reproductive tract"	Individual
350	"Increase, Mortality"	"Increase, Mortality"	Individual
351	"Increased, Mortality"	"Increased, Mortality"	Population
352	"N/A, Neurodegeneration"	"N/A, Neurodegeneration"	Tissue
356	"Increased, Oxidative damage"	"Increased, Oxidative damage"	Individual
357	"Cholestasis, Pathology"	"Cholestasis, Pathology"	Individual
358	"Increase, Pericardial edema"	"Increase, Pericardial edema"	Organ
360	"Decrease, Population trajectory"	"Decrease, Population trajectory"	Individual
361	"Decline, Population"	"Decline, Population"	Population
363	"Altered, Reproductive behaviour"	"Altered, Reproductive behaviour"	Individual
364	"Impaired development of, Reproductive organs"	"Impaired development of, Reproductive organs"	Individual
366	"Increased, Structural malformations"	"Increased, Structural malformations"	
369	Uroporphyria	Uroporphyria	Individual
373	"Formation, Pro-mutagenic DNA Adducts"	"Formation, Pro-mutagenic DNA Adducts"	Molecular
376	"Increased, Induced Mutations in Critical Genes"	"Increased, Induced Mutations in Critical Genes"	Cellular
377	"Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered Hepatic Foci (AHF))"	"Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H"	
378	"Tumorigenesis, Hepatocellular carcinoma"	"Tumorigenesis, Hepatocellular carcinoma"	Individual
380	"Activation, Pre-MIE: Metabolism of AFB1"	"Activation, Pre-MIE: Metabolism of AFB1"	Molecular
381	"Reduced, Release of BDNF"	"Reduced, Release of BDNF"	Molecular
382	"Aberrant, Dendritic morphology"	"Aberrant, Dendritic morphology"	Cellular
383	"Reduced, Presynaptic release of glutamate"	"Reduced, Presynaptic release of glutamate"	Molecular
384	"Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci"	"Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci"	
385	"Decreased, Synaptogenesis"	"Decreased, Synaptogenesis"	Cellular
386	"Decreased, Neuronal network function in developing brain"	"Decreased, Neuronal network function in developing brain"	Organ
387	"Binding of agonist, NMDARs"	"Binding of agonist, NMDARs"	Molecular
388	"Overactivation, NMDARs"	"Overactivation, NMDARs"	Molecular
389	"Increased, Intracellular Calcium overload"	"Increased, Intracellular Calcium overload"	Cellular
396	"Covalent Binding, Protein"	"Covalent Binding, Protein"	Molecular
397	"Response, Keratinocytes"	"Response, Keratinocytes"	Cellular
398	"Activation, Dendritic Cells"	"Activation, Dendritic Cells"	Cellular
401	"Increase, Biliary excretion TH glucuronide"	"Increase, Biliary excretion TH glucuronide"	Organ
402	"Cognitive Function, Decreased"	"Cognitive Function, Decreased"	Individual
403	"Suppression, Immune system"	"Suppression, Immune system"	Individual
405	"irregularities, ovarian cycle"	"irregularities, ovarian cycle"	Individual
406	"impaired, Fertility"	"impaired, Fertility"	Individual
408	"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"	"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"	Cellular
409	"Metabolism of AFB1, Production of Reactive Electrophiles"	"Metabolism of AFB1, Production of Reactive Electrophiles"	Molecular
413	"Reduction, Testosterone synthesis in Leydig cells"	"Reduction, Testosterone synthesis in Leydig cells"	Cellular
414	"Increase, Luteinizing hormone (LH)"	"Increase, Luteinizing hormone (LH)"	Cellular
415	"Hyperplasia, Leydig cell"	"Hyperplasia, Leydig cell"	Organ
416	"Increase proliferation, Leydig cell"	"Increase proliferation, Leydig cell"	Cellular
417	"skewed, sex ratio"	"skewed, sex ratio"	Population
418	"Increased, Vitellogenin synthesis"	"Increased, Vitellogenin synthesis"	Cellular
419	"Increased, renal vitellogenin deposition"	"Increased, renal vitellogenin deposition"	Organ
421	"Increased, glomerular rupture and renal hemorrhaging"	"Increased, glomerular rupture and renal hemorrhaging"	Organ
422	"Increased, nephropathy"	"Increased, nephropathy"	Individual
423	"Increased, Clonal Expansion / Cell Proliferation to Form Pre-Neoplastic Altered Hepatic Foci"	"Increased, Clonal Expansion / Cell Proliferation to Form Pre-Neoplastic Altered Hepatic Foc"	
424	"Inhibition, Na+/I- symporter (NIS)"	"Inhibition, Na+/I- symporter (NIS)"	Molecular
425	"Decreased, Thyroidal iodide uptake"	"Decreased, Thyroidal iodide uptake"	Cellular
426	"Decreased, Thyroxine (T4) in serum"	"Decreased, Thyroxine (T4) in serum"	Tissue
427	"Down Regulation, K-Cl co-transporter 2 (KCC2)"	"Down Regulation, K-Cl co-transporter 2 (KCC2)"	Cellular
428	"Delay, Developmental GABA shift"	"Delay, Developmental GABA shift"	Cellular
429	"Cellular Proliferation and Clonal Expansion of Mutant Cells (Pre-neoplastic Foci), Alteration of cellular growth homeostasis"	"Cellular Proliferation and Clonal Expansion of Mutant Cells (Pre-neoplastic Foci), Alterati"	
442	"Decreased, Population trajectory"	"Decreased, Population trajectory"	Individual
444	"Increased, Atrioventricular block and bradycardia"	"Increased, Atrioventricular block and bradycardia"	Organ
445	"Increased, Respiratory distress/arrest"	"Increased, Respiratory distress/arrest"	Organ
446	"Reduction, testosterone level"	"Reduction, testosterone level"	Individual
447	"Reduction, Cholesterol transport in mitochondria"	"Reduction, Cholesterol transport in mitochondria"	Cellular
450	"Suppression, VLDL secretion"	"Suppression, VLDL secretion"	Cellular
451	"Inhibition, Mitochondrial fatty acid beta-oxidation"	"Inhibition, Mitochondrial fatty acid beta-oxidation"	Molecular
454	"Increased, Triglyceride formation"	"Increased, Triglyceride formation"	Cellular
455	"Accumulation, Liver lipid"	"Accumulation, Liver lipid"	Organ
456	"Suppression, Constitutive androstane receptor, NR1l3"	"Suppression, Constitutive androstane receptor, NR1l3"	Molecular
457	"Activation, SREBF1"	"Activation, SREBF1"	Molecular
458	"Increased, De Novo FA synthesis"	"Increased, De Novo FA synthesis"	Cellular
459	"Increased, Liver Steatosis"	"Increased, Liver Steatosis"	Organ
460	"Increased, Fatty acid uptake"	"Increased, Fatty acid uptake"	Cellular
461	"Suppression, HNF4alpha"	"Suppression, HNF4alpha"	Molecular
462	"Up Regulation, SCD-1"	"Up Regulation, SCD-1"	Molecular
463	"Up Regulation, FAS"	"Up Regulation, FAS"	Molecular
464	"Increased, SCD-1"	"Increased, SCD-1"	Molecular
465	"Increased, FA Influx"	"Increased, FA Influx"	Cellular
466	"Up Regulation, LDLR (low density lipoprotein receptor)"	"Up Regulation, LDLR (low density lipoprotein receptor)"	Molecular
467	"Increased, LDL uptake"	"Increased, LDL uptake"	Cellular
468	"Inhibition, PPAR alpha"	"Inhibition, PPAR alpha"	Molecular
470	"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"	"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"	Molecular
471	"Inhibition, FoxA2"	"Inhibition, FoxA2"	Molecular
472	"Down Regulation, CPT1A"	"Down Regulation, CPT1A"	Molecular
474	"Down Regulation, HMGCS2"	"Down Regulation, HMGCS2"	Molecular
475	"Increased, Hepatic Triglycerides"	"Increased, Hepatic Triglycerides"	Tissue
476	"Accumulation, Hepatic FA"	"Accumulation, Hepatic FA"	Organ
477	"Decreased, Ketogenesis"	"Decreased, Ketogenesis"	Cellular
478	"Activation, NRF2"	"Activation, NRF2"	Molecular
479	"Activation, NR1H4"	"Activation, NR1H4"	Molecular
480	"Activation, SHP"	"Activation, SHP"	Molecular
482	"Decreased, DHB4/HSD17B4"	"Decreased, DHB4/HSD17B4"	Molecular
483	"Activation, LXR alpha"	"Activation, LXR alpha"	Molecular
484	"Activation, AKT2"	"Activation, AKT2"	Molecular
485	"Activtation, SREBP-1c"	"Activtation, SREBP-1c"	Molecular
486	systemic inflammation leading to hepatic steatosis	inflammation	Organ
488	"Decrease, Ovulation"	"Decrease, Ovulation"	Tissue
491	"Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF)"	"Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF)"	Organ
493	"Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts"	"Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts"	Molecular
494	"Activation of specific nuclear receptors, Glucocorticoid Receptor Agonist"	"Activation of specific nuclear receptors, Glucocorticoid Receptor Agonist"	Molecular
495	"Abnormal steroidogenic gene expression, Decreased testosterone by the Leydig cell"	"Abnormal steroidogenic gene expression, Decreased testosterone by the Leydig cell"	Cellular
496	"Increased Apoptosis, Decreased Leydig cells"	"Increased Apoptosis, Decreased Leydig cells"	Cellular
497	"Decreased Sperm Number, Reduced Fertility"	"Decreased Sperm Number, Reduced Fertility"	Individual
498	"Accelerated Epididymal Sperm Transit, Reduced Fertility"	"Accelerated Epididymal Sperm Transit, Reduced Fertility"	Individual
499	"Abnormal Sperm Maturation, Reduced Fertility"	"Abnormal Sperm Maturation, Reduced Fertility"	Individual
505	"Decreased sperm quantity / quality in the adult, Decreased fertility"	"Decreased sperm quantity / quality in the adult, Decreased fertility"	Individual
520	"Decreased sperm quantity or quality in the adult, Decreased fertility"	"Decreased sperm quantity or quality in the adult, Decreased fertility"	Individual
525	"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells"	"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells"	Cellular
526	"Inhibition, Inhibition of Dopamine-beta-hydroxylase"	"Inhibition, Inhibition of Dopamine-beta-hydroxylase"	Molecular
527	"Decreased, Decreased fecundity"	"Decreased, Decreased fecundity"	Individual
528	"Decreased, Synthesis of NE"	"Decreased, Synthesis of NE"	Cellular
529	"Decreased, GnRH cfos activity"	"Decreased, GnRH cfos activity"	Molecular
530	"Decreased, GnRH pulsatility/release"	"Decreased, GnRH pulsatility/release"	Cellular
531	"Decreased, LH Surge"	"Decreased, LH Surge"	Cellular
532	"Delayed, Ovulation"	"Delayed, Ovulation"	Individual
533	"Decreased, Cortical granule release/distribution upon fertilization"	"Decreased, Cortical granule release/distribution upon fertilization"	Cellular
534	"Altered, Formation of cortical envelope"	"Altered, Formation of cortical envelope"	Cellular
535	"Abnormal, Sperm penetration (polyspermy)"	"Abnormal, Sperm penetration (polyspermy)"	Cellular
536	"Altered, Chromosome number (polyploid) zygote"	"Altered, Chromosome number (polyploid) zygote"	Cellular
540	"Decreased testosterone by the fetal Leydig cells, Dysgensis of fetal Leydig cells"	"Decreased testosterone by the fetal Leydig cells, Dysgensis of fetal Leydig cells"	Organ
541	"Decreased testosterone by the fetal Leydig cells, Decreased COUP-TFII stem Leydig cells"	"Decreased testosterone by the fetal Leydig cells, Decreased COUP-TFII stem Leydig cells"	Cellular
543	"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis"	"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult test"	Individual
559	"Activation, Nicotinic acetylcholine receptor"	"Activation, Nicotinic acetylcholine receptor"	Molecular
560	"Abnormal, Foraging activity and behavior"	"Abnormal, Foraging activity and behavior"	Individual
561	"Reduced, Food storage"	"Reduced, Food storage"	Population
563	"Death/Failure, Colony"	"Death/Failure, Colony"	Population
564	"Abnormal, Roll change within caste"	"Abnormal, Roll change within caste"	Population
565	"Reduced, Brood care"	"Reduced, Brood care"	Population
566	"impaired, Larval development"	"impaired, Larval development"	Population
568	"impaired, Hive thermoregulation"	"impaired, Hive thermoregulation"	Population
570	"Accumulation, Damaged mitochondrial DNA"	"Accumulation, Damaged mitochondrial DNA"	Cellular
571	"Accelerated, Aging"	"Accelerated, Aging"	Individual
572	"Decrease, Number of worker bees"	"Decrease, Number of worker bees"	Population
573	"Increase, Energetic demands and therefore metabolic stress"	"Increase, Energetic demands and therefore metabolic stress"	Individual
574	"Increased, Appetite and hunger"	"Increased, Appetite and hunger"	Individual
576	"Increased, Viral susceptibility"	"Increased, Viral susceptibility"	Individual
577	"impaired, Development"	"impaired, Development"	Individual
578	"Decreased, Glucose oxidase enzyme activity"	"Decreased, Glucose oxidase enzyme activity"	Molecular
579	"Decreased, Hydrogen peroxide production"	"Decreased, Hydrogen peroxide production"	Molecular
580	"Reduced, Antiseptic incorporated in food"	"Reduced, Antiseptic incorporated in food"	Population
583	"impaired, Thoracic shivering"	"impaired, Thoracic shivering"	Individual
584	"Inhibition, sodium channel"	"Inhibition, sodium channel"	Molecular
585	"Decreased, Sodium conductance 1"	"Decreased, Sodium conductance 1"	Cellular
586	"Reduced, swimming speed"	"Reduced, swimming speed"	Individual
587	"Reduced, feeding 1"	"Reduced, feeding 1"	Individual
588	"Increased, predation"	"Increased, predation"	Population
590	"N/A, hypoxia"	"N/A, hypoxia"	Tissue
591	"Increased, amputations"	"Increased, amputations"	Individual
592	"Reduced, survival"	"Reduced, survival"	Population
593	"Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel"	"Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel"	Molecular
598	"modulation, sodium channel"	"modulation, sodium channel"	Molecular
599	"prolonged, Depolarization of neuronal membrane"	"prolonged, Depolarization of neuronal membrane"	Cellular
600	"Overactivation, Neuronotransmitter release"	"Overactivation, Neuronotransmitter release"	Molecular
601	"Overactivation, muscle contraction"	"Overactivation, muscle contraction"	Tissue
602	"Increased, Ataxia, paralysis, or hyperactivity"	"Increased, Ataxia, paralysis, or hyperactivity"	Organ
613	"Occurrence, Epileptic seizure"	"Occurrence, Epileptic seizure"	Individual
616	"Occurrence, A paroxysmal depolarizing shift"	"Occurrence, A paroxysmal depolarizing shift"	Tissue
618	"Decreased, Neuronal network function in adult brain"	"Decreased, Neuronal network function in adult brain"	Organ
619	"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"	"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"	Molecular
620	"Increased, serotonin (5-HT) 1 1"	"Increased, serotonin (5-HT) 1"	Molecular
621	"Increase, cilia movement"	"Increase, cilia movement"	Tissue
622	"Increased, locomotion"	"Increased, locomotion"	Individual
623	"Increase, predation"	"Increase, predation"	Population
624	"Increased, foot detachment"	"Increased, foot detachment"	Individual
625	"Increased, muscular waves in foot"	"Increased, muscular waves in foot"	Organ
626	"Increased, serotonin (5-HT)"	"Increased, serotonin (5-HT)"	Cellular
627	"Decreased, anxiety"	"Decreased, anxiety"	Individual
629	"Decreased, sheltering"	"Decreased, sheltering"	Individual
633	"Decrease, histaminergic neuron excitation"	"Decrease, histaminergic neuron excitation"	Cellular
634	"N/A, sedation"	"N/A, sedation"	Individual
635	"Decreased, locomotion"	"Decreased, locomotion"	Individual
636	"Decreased, survival"	"Decreased, survival"	Population
637	"impaired, Learning and memory"	"impaired, Learning and memory"	Individual
638	"Antagonism, Histamine Receptor (H2)"	"Antagonism, Histamine Receptor (H2)"	Molecular
640	"Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell"	"Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell"	Molecular
642	"Decreased Cholesterol, Decreased De Novo Biosynthesis of Choleseterol"	"Decreased Cholesterol, Decreased De Novo Biosynthesis of Choleseterol"	Molecular
643	"Decreased Cholesterol, Decreased Uptake of Lipoproteins"	"Decreased Cholesterol, Decreased Uptake of Lipoproteins"	Molecular
644	"Decreased Cholesterol, Decreased Transport of Cholesterol to the Inner Mitochondrial Membrane"	"Decreased Cholesterol, Decreased Transport of Cholesterol to the Inner Mitochondrial Membra"	Molecular
645	"Decreased Cholesterol, Decreased Testosterone Production by Adult Leydig Cells"	"Decreased Cholesterol, Decreased Testosterone Production by Adult Leydig Cells"	Cellular
646	"Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis"	"Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis"	Organ
647	"Decreased steroidogenesis, Decreased Activity of Steroidogenic Enzymes in Adult Leydig cells"	"Decreased steroidogenesis, Decreased Activity of Steroidogenic Enzymes in Adult Leydig cell"	Cellular
648	"Decreased steroidogenesis, Increased Apoptosis of Adult Leydig Cells"	"Decreased steroidogenesis, Increased Apoptosis of Adult Leydig Cells"	Tissue
649	"Decreased steroidogenesis, Alterations in the Leydig Cell Cytoskeleton"	"Decreased steroidogenesis, Alterations in the Leydig Cell Cytoskeleton"	Tissue
650	"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid"	"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid"	Molecular
651	"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells"	"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testostero"	Cellular
652	"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells"	"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig"	Cellular
653	"Decreased testosterone by the fetal Leydig cells, Increased corticosterone"	"Decreased testosterone by the fetal Leydig cells, Increased corticosterone"	Cellular
654	"Decreased testosterone by the fetal Leydig cells, Activation by other glucocorticoid receptor agonists"	"Decreased testosterone by the fetal Leydig cells, Activation by other glucocorticoid recept"	Cellular
655	"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"	"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"	Cellular
656	"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"	"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"	Cellular
657	"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells"	"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells"	Organ
658	"Decreased testosterone by the fetal Leydig cells, Increased estradiol"	"Decreased testosterone by the fetal Leydig cells, Increased estradiol"	Cellular
659	"Decreased testosterone by the fetal Leydig cells, Activation by other estradiol agonists"	"Decreased testosterone by the fetal Leydig cells, Activation by other estradiol agonists"	Cellular
660	"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells"	"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells"	Organ
661	"Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome"	"Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome"	Molecular
662	"Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis"	"Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis"	Molecular
663	"Desensitization, Nicotinic acetylcholine receptor"	"Desensitization, Nicotinic acetylcholine receptor"	Molecular
664	"Overwhelmed, Mitochondrial DNA repair mechanisms"	"Overwhelmed, Mitochondrial DNA repair mechanisms"	Cellular
667	"Binding at picrotoxin site, iGABAR chloride channel"	"Binding at picrotoxin site, iGABAR chloride channel"	Molecular
669	"Reduction, Neuronal synaptic inhibition"	"Reduction, Neuronal synaptic inhibition"	Cellular
671	"Reduced, Prostaglandin F2alpha concentration, plasma"	"Reduced, Prostaglandin F2alpha concentration, plasma"	Individual
672	"Reduced, Prostaglandin F2alpha synthesis, ovary"	"Reduced, Prostaglandin F2alpha synthesis, ovary"	Organ
673	"Reduced, Spawning behavior"	"Reduced, Spawning behavior"	Individual
674	"Reduced, Ability to attract spawning mates"	"Reduced, Ability to attract spawning mates"	Individual
675	"Reduced, Reproductive Success"	"Reduced, Reproductive Success"	Individual
678	"Reduced, Pheromone release"	"Reduced, Pheromone release"	Individual
679	"Decline, Population trajectory"	"Decline, Population trajectory"	Population
681	"Decreased, Prostaglandin F2alpha synthesis, ovary"	"Decreased, Prostaglandin F2alpha synthesis, ovary"	Organ
682	"Generation, Amplified excitatory postsynaptic potential (EPSP)"	"Generation, Amplified excitatory postsynaptic potential (EPSP)"	Tissue
685	"Reduced, Prostaglandins, ovary"	"Reduced, Prostaglandins, ovary"	Organ
686	"Declining, Population trajectory"	"Declining, Population trajectory"	Population
687	"Reduced, Prostaglandin E2 concentration, hypothalamus"	"Reduced, Prostaglandin E2 concentration, hypothalamus"	Tissue
689	"Reduced, Gonadotropin releasing hormone, hypothalamus"	"Reduced, Gonadotropin releasing hormone, hypothalamus"	Tissue
690	"Reduced, Luteinizing hormone (LH), plasma"	"Reduced, Luteinizing hormone (LH), plasma"	Tissue
691	"Reduced, Maturation inducing steroid, plasma"	"Reduced, Maturation inducing steroid, plasma"	Tissue
692	"Reduced, Maturation inducing steroid receptor signalling, oocyte"	"Reduced, Maturation inducing steroid receptor signalling, oocyte"	Tissue
693	"Increased, cyclic adenosine monophosphate"	"Increased, cyclic adenosine monophosphate"	Tissue
694	"Reduced, Meiotic prophase I/metaphase I transition, oocyte"	"Reduced, Meiotic prophase I/metaphase I transition, oocyte"	Cellular
695	"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"	"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"	Molecular
696	"Increased, Chromosome misseggregation"	"Increased, Chromosome misseggregation"	Cellular
697	"impaired, ion channels"	"impaired, ion channels"	Cellular
698	"Altered, Action Potential"	"Altered, Action Potential"	Cellular
699	"Increased, cardiac arrthymia"	"Increased, cardiac arrthymia"	Organ
708	"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)"	"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)"	Tissue
709	"Increase, Cytotoxicity (renal tubular cell)"	"Increase, Cytotoxicity (renal tubular cell)"	Cellular
710	"Increase, Regenerative cell proliferation (tubular epithelial cells)"	"Increase, Regenerative cell proliferation (tubular epithelial cells)"	Cellular
713	"Increase, Adenomas/carcinomas (renal tubular)"	"Increase, Adenomas/carcinomas (renal tubular)"	Tissue
714	"Increased, Binding of chemicals to 2u (serum)"	"Increased, Binding of chemicals to 2u (serum)"	Molecular
715	"Activation, Constitutive androstane receptor"	"Activation, Constitutive androstane receptor"	Molecular
716	"Increase, Mitogenic cell proliferation (hepatocytes)"	"Increase, Mitogenic cell proliferation (hepatocytes)"	Cellular
718	"Binding, Tubulin"	"Binding, Tubulin"	Molecular
719	"Increase, Adenomas/carcinomas (hepatocellular)"	"Increase, Adenomas/carcinomas (hepatocellular)"	Tissue
720	"Depolymerization, Microtubule"	"Depolymerization, Microtubule"	Molecular
721	"Disorganization, Spindle"	"Disorganization, Spindle"	Cellular
723	"Altered, Chromosome number"	"Altered, Chromosome number"	Cellular
724	"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme"	"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme"	Cellular
726	"Increased, Induction of pyruvate dehydrogenase (PDH)"	"Increased, Induction of pyruvate dehydrogenase (PDH)"	Molecular
728	"Increase, Aneuploid offspring"	"Increase, Aneuploid offspring"	Individual
733	"Increase, Necrosis (terminal bronchiolar cells)"	"Increase, Necrosis (terminal bronchiolar cells)"	Cellular
734	"Increase, Regenerative cell proliferation (terminal bronchiolar epithelial cells)"	"Increase, Regenerative cell proliferation (terminal bronchiolar epithelial cells)"	Cellular
735	"Increase, Hyperplasia (terminal bronchiolar cells)"	"Increase, Hyperplasia (terminal bronchiolar cells)"	Cellular
736	"Increase, Adenomas/carcinomas (bronchioloalveolar)"	"Increase, Adenomas/carcinomas (bronchioloalveolar)"	Tissue
737	"Decreased, Uptake of inorganic iodide"	"Decreased, Uptake of inorganic iodide"	Cellular
739	"Increase, Hypertrophy and proliferation (follicular cell)"	"Increase, Hypertrophy and proliferation (follicular cell)"	Cellular
740	"Increase, Hyperplasia (follicular cells)"	"Increase, Hyperplasia (follicular cells)"	Cellular
741	"Increase, Adenomas/carcinomas (follicular cell)"	"Increase, Adenomas/carcinomas (follicular cell)"	Tissue
742	"Decreased, Androgen receptor activity"	"Decreased, Androgen receptor activity"	Molecular
743	"Decreased, Testosterone binding to androgen receptor (hypothalamus)"	"Decreased, Testosterone binding to androgen receptor (hypothalamus)"	Molecular
744	"Increase, Hyperplasia (Leydig cells)"	"Increase, Hyperplasia (Leydig cells)"	Cellular
745	"Increase, Leydig cell tumors"	"Increase, Leydig cell tumors"	Cellular
746	"Increase, Dopaminergic activity"	"Increase, Dopaminergic activity"	Cellular
747	"Decreased, Prolactin"	"Decreased, Prolactin"	Tissue
748	"Increased, Estrogen receptor (ER) activity"	"Increased, Estrogen receptor (ER) activity"	Molecular
749	"Decreased, Progesterone from corpus luteum"	"Decreased, Progesterone from corpus luteum"	Tissue
752	"Altered, Meiotic chromosome dynamics"	"Altered, Meiotic chromosome dynamics"	Cellular
753	"Increase, Thyroid-stimulating hormone (TSH)"	"Increase, Thyroid-stimulating hormone (TSH)"	Tissue
754	"Increased, Luteinizing hormone (LH)"	"Increased, Luteinizing hormone (LH)"	Tissue
756	"Hippocampal gene expression, Altered"	"Hippocampal gene expression, Altered"	Tissue
757	"Hippocampal anatomy, Altered"	"Hippocampal anatomy, Altered"	Organ
758	"Hippocampal Physiology, Altered"	"Hippocampal Physiology, Altered"	Tissue
759	"Increased, Kidney Failure"	"Increased, Kidney Failure"	Individual
760	"Activation, Glutamate-gated chloride channel"	"Activation, Glutamate-gated chloride channel"	Molecular
761	"Increased, Chloride conductance"	"Increased, Chloride conductance"	Cellular
762	"Activation, ionotropic GABA Receptor chloride channel"	"Activation, ionotropic GABA Receptor chloride channel"	Molecular
763	"hyperpolarisation, neuron"	"hyperpolarisation, neuron"	Cellular
764	"N/A, Ataxia, paralysis, or hyperactivity"	"N/A, Ataxia, paralysis, or hyperactivity"	Organ
765	"Decreased, population 1"	"Decreased, population 1"	Population
766	"Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme"	"Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme"	Molecular
767	"Increase, Hyperplasia (renal tubular cells)"	"Increase, Hyperplasia (renal tubular cells)"	Cellular
768	"Increase, Cytotoxicity"	"Increase, Cytotoxicity"	Cellular
769	"Increase, Oxidative metabolism"	"Increase, Oxidative metabolism"	Cellular
770	"Increase, Cytotoxicity (club cells)"	"Increase, Cytotoxicity (club cells)"	Cellular
771	"Decrease, Serum thyroid hormone (T4/T3)"	"Decrease, Serum thyroid hormone (T4/T3)"	Tissue
772	"Increase, Hyperplasia (glandular epithelial cells of endometrium)"	"Increase, Hyperplasia (glandular epithelial cells of endometrium)"	Cellular
773	"Increase, Endometrial adenocarcinomas"	"Increase, Endometrial adenocarcinomas"	Tissue
774	"Increase, Preneoplastic foci (hepatocytes)"	"Increase, Preneoplastic foci (hepatocytes)"	Cellular
775	"Increased, Plasma tyrosine"	"Increased, Plasma tyrosine"	Tissue
776	"Increase, Cytotoxicity (corneal cells)"	"Increase, Cytotoxicity (corneal cells)"	Cellular
777	"Increase, Inflammation (corneal cells)"	"Increase, Inflammation (corneal cells)"	Cellular
778	"Increase, Regenerative cell proliferation (corneal cells)"	"Increase, Regenerative cell proliferation (corneal cells)"	Cellular
779	"Increase, Papillomas/carcinomas (squamous cells)"	"Increase, Papillomas/carcinomas (squamous cells)"	Cellular
780	"Increase, Cytotoxicity (epithelial cells)"	"Increase, Cytotoxicity (epithelial cells)"	Cellular
781	"Increase, Regenerative cell proliferation (forestomach epithelial cells)"	"Increase, Regenerative cell proliferation (forestomach epithelial cells)"	Cellular
782	"Increase, Hyperplasia (forestomach epithelial cells)"	"Increase, Hyperplasia (forestomach epithelial cells)"	Cellular
783	"Increase, Cytotoxicity (tubular epithelial cells)"	"Increase, Cytotoxicity (tubular epithelial cells)"	Cellular
784	"Increase, Hyperplasia (tubular epithelial cells)"	"Increase, Hyperplasia (tubular epithelial cells)"	Cellular
785	"Activation, Androgen receptor"	"Activation, Androgen receptor"	Molecular
786	"Increase, Cytotoxicity (hepatocytes)"	"Increase, Cytotoxicity (hepatocytes)"	Cellular
787	"Increase, Regenerative cell proliferation (hepatocytes)"	"Increase, Regenerative cell proliferation (hepatocytes)"	Cellular
788	"Decrease, Incorporation of active iodide into iodotyrosines"	"Decrease, Incorporation of active iodide into iodotyrosines"	Cellular
790	"Inhibition, 5?-reductase activity"	"Inhibition, 5?-reductase activity"	Cellular
791	"Increased, Leutinizing hormone (LH)"	"Increased, Leutinizing hormone (LH)"	Tissue
792	"Decrease, Bioactivation of testosterone"	"Decrease, Bioactivation of testosterone"	Tissue
793	"Increase, Urinary bladder calculi"	"Increase, Urinary bladder calculi"	Organ
794	"Increase, Cytotoxicity (urothelial cells)"	"Increase, Cytotoxicity (urothelial cells)"	Cellular
795	"Increase, Regenerative cell proliferation (urothelial cells)"	"Increase, Regenerative cell proliferation (urothelial cells)"	Cellular
796	"Increase, Hyperplasia (urothelial)"	"Increase, Hyperplasia (urothelial)"	Cellular
797	"Increase, Adenomas/carcinomas (urothelial)"	"Increase, Adenomas/carcinomas (urothelial)"	Tissue
798	"Inhibition, Prolyl hydroxylases"	"Inhibition, Prolyl hydroxylases"	Cellular
799	"Increased, HIF-1 heterodimer"	"Increased, HIF-1 heterodimer"	Cellular
800	"Decreased, Aromatase (Cyp19a1) mRNA"	"Decreased, Aromatase (Cyp19a1) mRNA"	Cellular
801	"modulation, Unknown"	"modulation, Unknown"	Molecular
802	"Increased, HIF-1 alpha transcription"	"Increased, HIF-1 alpha transcription"	Cellular
804	"Inhibition, HMG-CoA reductase"	"Inhibition, HMG-CoA reductase"	Cellular
805	"Decreased, mevalonate"	"Decreased, mevalonate"	Cellular
807	"Decreased, cholesterol"	"Decreased, cholesterol"	Cellular
808	"Decreased, Testosterone"	"Decreased, Testosterone"	Individual
809	"malformed, Male reproductive tract"	"malformed, Male reproductive tract"	Individual
813	"Increased, Serum creatinine"	"Increased, Serum creatinine"	Organ
814	"Occurrence, Kidney toxicity"	"Occurrence, Kidney toxicity"	Organ
818	"Occurrence, Cytoplasmic vacuolization (Renal tubule)"	"Occurrence, Cytoplasmic vacuolization (Renal tubule)"	Organ
819	"Decreased, Glomerular filtration"	"Decreased, Glomerular filtration"	Tissue
820	"Decreased, Renal plasma flow"	"Decreased, Renal plasma flow"	Tissue
821	"Decreased, Sodium reabsorption"	"Decreased, Sodium reabsorption"	Organ
823	"Occurrence, Cystic dilatation (renal tubule)"	"Occurrence, Cystic dilatation (renal tubule)"	Organ
824	"Occurrence, Cytoplasmic vacuolization (podocyte)"	"Occurrence, Cytoplasmic vacuolization (podocyte)"	Organ
825	"Decreased, Renal ability to dilute urine"	"Decreased, Renal ability to dilute urine"	Organ
826	"Activation, Keratinocytes"	"Activation, Keratinocytes"	Cellular
827	"sensitisation, skin"	"sensitisation, skin"	Organ
828	"Inhibition, Phospholipase A"	"Inhibition, Phospholipase A"	Molecular
829	"Damage, Lipid bilayer"	"Damage, Lipid bilayer"	Cellular
831	"Disturbance, Lysosomal function"	"Disturbance, Lysosomal function"	Cellular
832	"Injury, Mitochondria"	"Injury, Mitochondria"	Cellular
833	"Occurrence, Cytoplasmic vacuolization (hepatocyte)"	"Occurrence, Cytoplasmic vacuolization (hepatocyte)"	Cellular
835	"Occurrence, Ballooning degeneration (hepatocyte)"	"Occurrence, Ballooning degeneration (hepatocyte)"	Cellular
836	"Occurrence, Cytoplasmic vacuolization (Bile duct cell)"	"Occurrence, Cytoplasmic vacuolization (Bile duct cell)"	Cellular
837	"Occurrence, Cytoplasmic vacuolization (kupffer cell)"	"Occurrence, Cytoplasmic vacuolization (kupffer cell)"	Cellular
838	"Induction, Microvesicular fat"	"Induction, Microvesicular fat"	Tissue
839	"Formation, Mallory body"	"Formation, Mallory body"	Cellular
840	"Formation, Liver fibrosis"	"Formation, Liver fibrosis"	Tissue
844	"Oxidation, Uroporphyrinogen"	"Oxidation, Uroporphyrinogen"	Cellular
845	"Inhibition, UROD"	"Inhibition, UROD"	Molecular
846	"Accumulation, Highly carboxylated porphyrins"	"Accumulation, Highly carboxylated porphyrins"	Organ
848	"Decreased, Binding of NE to NE receptors on GnRH neurons"	"Decreased, Binding of NE to NE receptors on GnRH neurons"	Cellular
849	"Inhibition, Antgonism of NE receptor"	"Inhibition, Antgonism of NE receptor"	Molecular
850	"Induction, CYP1A2/CYP1A5"	"Induction, CYP1A2/CYP1A5"	Molecular
851	"Altered, GABAergic interneurons morphology and function"	"Altered, GABAergic interneurons morphology and function"	Cellular
853	"Changes/Inhibition, Cellular Homeostasis and Apoptosis"	"Changes/Inhibition, Cellular Homeostasis and Apoptosis"	Cellular
854	"Alterations, Cellular proliferation / hyperplasia"	"Alterations, Cellular proliferation / hyperplasia"	Tissue
856	"Formation, Hepatocellular and Bile duct tumors"	"Formation, Hepatocellular and Bile duct tumors"	Organ
857	"Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain"	"Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain"	Molecular
858	"Decreased, PPARalpha transactivation of gene expression"	"Decreased, PPARalpha transactivation of gene expression"	Molecular
859	"Decreased, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids"	"Decreased, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids"	Molecular
860	"Decreased, Mitochondrial Fatty Acid Beta Oxidation"	"Decreased, Mitochondrial Fatty Acid Beta Oxidation"	Molecular
861	"Decreased, Ketogenesis (production of ketone bodies)"	"Decreased, Ketogenesis (production of ketone bodies)"	Molecular
862	"Not Increased, Circulating Ketone Bodies"	"Not Increased, Circulating Ketone Bodies"	Tissue
863	"Increased, Catabolism of Muscle Protein"	"Increased, Catabolism of Muscle Protein"	Organ
864	"Decreased, Body Weight"	"Decreased, Body Weight"	Individual
867	"Decrease, Intracellular pH"	"Decrease, Intracellular pH"	Cellular
868	"Increase, Tissue Degeneration, Necrosis & Atrophy"	"Increase, Tissue Degeneration, Necrosis & Atrophy"	Tissue
869	"Increase, Respiratory or Squamous Metaplasia"	"Increase, Respiratory or Squamous Metaplasia"	Tissue
870	"Increase, Cell Proliferation"	"Increase, Cell Proliferation"	Cellular
872	"Increase, Site of Contact Nasal Tumors"	"Increase, Site of Contact Nasal Tumors"	Organ
875	"Binding of agonist, Ionotropic glutamate receptors"	"Binding of agonist, Ionotropic glutamate receptors"	Molecular
876	"Increase, Mutations in Critical Genes"	"Increase, Mutations in Critical Genes"	Molecular
877	"Inhibition, organic anion transporter 1 (OAT1)"	"Inhibition, organic anion transporter 1 (OAT1)"	Molecular
878	"Inhibition, SREBP1c"	"Inhibition, SREBP1c"	Molecular
879	"Activation, MTTP"	"Activation, MTTP"	Cellular
880	"Increased, ApoB100"	"Increased, ApoB100"	Tissue
881	"Increased, Triglyceride"	"Increased, Triglyceride"	Cellular
882	"Decreased, De Novo FA synthesis"	"Decreased, De Novo FA synthesis"	Cellular
885	"Increase, Cancer"	"Increase, Cancer"	Tissue
887	"Inhibition, NADH-ubiquinone oxidoreductase (complex I)"	"Inhibition, NADH-ubiquinone oxidoreductase (complex I)"	Cellular
888	"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"	"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"	Molecular
889	"impaired, Proteostasis"	"impaired, Proteostasis"	Cellular
890	Degeneration of dopaminergic neurons of the nigrostriatal pathway	Degeneration of dopaminergic neurons of the nigrostriatal pathway	Organ
896	Parkinsonian motor deficits	Parkinsonian motor deficits	Individual
898	"Disruption, Lysosome"	"Disruption, Lysosome"	Cellular
901	"Infiltration, Inflammatory cells"	"Infiltration, Inflammatory cells"	Tissue
902	"Inflammation, Liver"	"Inflammation, Liver"	Organ
907	"Infiltration, Inflammatory cytokines"	"Infiltration, Inflammatory cytokines"	
913	"Activation, Epidermal Growth Factor Receptor"	"Activation, Epidermal Growth Factor Receptor"	
914	"Decrease, Apoptosis of ciliated epithelial cells"	"Decrease, Apoptosis of ciliated epithelial cells"	Cellular
919	"Increase, Transdifferentiation of ciliated epithelial cells"	"Increase, Transdifferentiation of ciliated epithelial cells"	Cellular
920	"Increase, Metaplasia of goblet cells"	"Increase, Metaplasia of goblet cells"	Tissue
921	"Increase, Hyperplasia of goblet cells"	"Increase, Hyperplasia of goblet cells"	Tissue
923	"Increase, Proliferation of goblet cells"	"Increase, Proliferation of goblet cells"	Cellular
924	"Activation, SP1"	"Activation, SP1"	Molecular
926	"Oxidation, Glutathione"	"Oxidation, Glutathione"	Molecular
927	"S-Glutathionylation, eNOS"	"S-Glutathionylation, eNOS"	Molecular
932	"Uncoupling, eNOS"	"Uncoupling, eNOS"	Cellular
933	"Depletion, Nitric Oxide"	"Depletion, Nitric Oxide"	Cellular
934	"Decrease, Tetrahydrobiopterin"	"Decrease, Tetrahydrobiopterin"	Cellular
935	"Decrease, GTPCH-1"	"Decrease, GTPCH-1"	Cellular
937	"impaired, Vasodilation"	"impaired, Vasodilation"	Organ
941	"Activation, EGFR"	"Activation, EGFR"	Molecular
943	"Hypersecretion, Mucus"	"Hypersecretion, Mucus"	Organ
944	"dimerization, AHR/ARNT"	"dimerization, AHR/ARNT"	Molecular
945	"reduced dimerization, ARNT/HIF1-alpha"	"reduced dimerization, ARNT/HIF1-alpha"	Molecular
947	"Increase, Embryolethality"	"Increase, Embryolethality"	Individual
948	"reduced production, VEGF"	"reduced production, VEGF"	Cellular
951	"Increase, Vascular Resistance"	"Increase, Vascular Resistance"	Organ
952	"N/A, Hypertension"	"N/A, Hypertension"	Individual
957	"Binding, Transthyretin in serum"	"Binding, Transthyretin in serum"	Molecular
958	"Displacement, Serum thyroxine (T4) from transthyretin"	"Displacement, Serum thyroxine (T4) from transthyretin"	Molecular
959	"Increased, Free serum thyroxine (T4)"	"Increased, Free serum thyroxine (T4)"	Tissue
960	"Increased, Uptake of thyroxine into tissue"	"Increased, Uptake of thyroxine into tissue"	Cellular
961	"Increased, Clearance of thyroxine from tissues"	"Increased, Clearance of thyroxine from tissues"	Tissue
962	"Increase, Mucin production"	"Increase, Mucin production"	Cellular
964	"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol"	"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle b"	Molecular
965	"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic production of estradiol in granulosa cells"	"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic producti"	Cellular
966	"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation"	"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulos"	Tissue
967	"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus"	"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation de"	Organ
968	"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces kisspeptinergic neuron response"	"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces"	Cellular
969	"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons"	"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons"	Cellular
970	"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs"	"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituit"	Cellular
971	"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required for ovulation"	"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required f"	Individual
972	"Decreased fertility, Reduced number of oocytes ovulated"	"Decreased fertility, Reduced number of oocytes ovulated"	Individual
973	"Decrease, Akt/eNOS activity"	"Decrease, Akt/eNOS activity"	Cellular
974	"The binding of FK506 with FKBP12,"	"The binding of FK506 with FKBP12,"	
975	"The binding of FK506 with FKBP12, The binding of FK506 with FKBP12"	"The binding of FK506 with FKBP12, The binding of FK506 with FKBP12"	
976	"Formation, The binding of FK506 with FKBP12"	"Formation, The binding of FK506 with FKBP12"	Molecular
977	"Binding, Binding of calcineurin with FK506-FKBP complexes"	"Binding, Binding of calcineurin with FK506-FKBP complexes"	
978	"Activation, Suppression of NFAT activation and hindrance of nuclear localization"	"Activation, Suppression of NFAT activation and hindrance of nuclear localization"	Molecular
979	"Inhibition, Interference of NFAT complex formation at the site of nuclear cytokine promoters"	"Inhibition, Interference of NFAT complex formation at the site of nuclear cytokine promoter"	Molecular
980	"Binding, Formation, Binding of calcineurin with FK506-FKBP complexes"	"Binding, Formation, Binding of calcineurin with FK506-FKBP complexes"	Molecular
981	"Suppression, Suppression of cytokine production in the presence of T-cell activation"	"Suppression, Suppression of cytokine production in the presence of T-cell activation"	Cellular
982	"Suppression, Suppression in mixed lymphocyte reaction (MLR)"	"Suppression, Suppression in mixed lymphocyte reaction (MLR)"	Cellular
983	"Suppression, Suppression of T-cell dependent antibody response (TDAR)"	"Suppression, Suppression of T-cell dependent antibody response (TDAR)"	Cellular
984	"Suppression, Suppression of transplant rejection"	"Suppression, Suppression of transplant rejection"	Individual
985	"Relief, Relief of atopic dermatitis"	"Relief, Relief of atopic dermatitis"	Individual
986	"Increase, Increased susceptibility to infection"	"Increase, Increased susceptibility to infection"	Individual
987	", Metaplasia of goblet cells"	", Metaplasia of goblet cells"	
988	"Reduction, Release of circulating ecdysis triggering hormone"	"Reduction, Release of circulating ETH"	Tissue
989	"Decreased, synthesis and secretion of molting fluid proteases"	"Decreased, synthesis and secretion of molting fluid proteases"	
990	"Induction, Incomplete ecdysis"	"Induction, Incomplete ecdysis"	Individual
991	"Increased, Alterations of food-web structures"	"Increased, Alterations of food-web structures"	
992	"Decreased, Population 2"	"Decreased, Population 2"	
993	"Reduction, Abdominal muscle contraction"	"Reduction, Abdominal muscle contraction"	Tissue
994	"Decreased, Synthesis of molting fluid proteases"	"Decreased, Synthesis of molting fluid proteases"	Tissue
995	"Alterations, Food-web structures"	"Alterations, Food-web structures"	Population
996	"Decreased, Digestion of old cuticle"	"Decreased, Digestion of old cuticle"	Organ
997	"Decreased, Population size"	"Decreased, Population size"	Population
998	"Binding of antagonist, PPAR alpha"	"Binding of antagonist, PPAR alpha"	Molecular
999	"stabilization, co-repressor"	"stabilization, co-repressor"	
1000	"stabilization, PPAR alpha co-repressor"	"stabilization, PPAR alpha co-repressor"	Molecular
1001	"Increased, Developmental Defects"	"Increased, Developmental Defects"	Molecular
1002	"Inhibition, Deiodinase 2"	"Inhibition, Deiodinase 2"	Molecular
1003	"Decreased, Triiodothyronine (T3) in serum"	"Decreased, Triiodothyronine (T3) in serum"	Cellular
1004	"Reduced, Posterior swim bladder inflation"	"Reduced, Posterior swim bladder inflation"	Organ
1005	"Reduced, Swimming performance"	"Reduced, Swimming performance"	Individual
1006	"Reduced, Young of year survival"	"Reduced, Young of year survival"	Individual
1007	"Reduced, Anterior swim bladder inflation"	"Reduced, Anterior swim bladder inflation"	Tissue
1008	"Reduced, Hearing"	"Reduced, Hearing"	Organ
1009	"Inhibition, Deiodinase 1"	"Inhibition, Deiodinase 1"	Molecular
1010	"Activation, iGABAR chloride channel"	"Activation, iGABAR chloride channel"	
1011	"Increased, Chloride influx"	"Increased, Chloride influx"	
1012	"Increased, Inhibitory postsynaptic potential"	"Increased, Inhibitory postsynaptic potential"	Cellular
1013	"Inhibition, Motor neuron activity"	"Inhibition, Motor neuron activity"	
1014	"Induction, Somatic muscle paralysis"	"Induction, Somatic muscle paralysis"	Tissue
1015	"Increased, Neuronal synaptic inhibition"	"Increased, Neuronal synaptic inhibition"	Cellular
1016	"Inhibition, Feeding"	"Inhibition, Feeding"	Individual
1017	"Reduced, Feeding 2"	"Reduced, Feeding 2"	
1018	"Activation, Glutamate-gated chloride channels"	"Activation, Glutamate-gated chloride channels"	Molecular
1019	"Induction, pharyngeal muscle paralysis"	"Induction, pharyngeal muscle paralysis"	Tissue
1020	"Increased, induction of UDPGT's in liver"	"Increased, induction of UDPGT's in liver"	Cellular
1021	"Increased, T4/T3 catabolism"	"Increased, T4/T3 catabolism"	Cellular
1022	"Decreased, serum T4/T3"	"Decreased, serum T4/T3"	Tissue
1023	"Increased, Thyroid-stimulating hormone (TSH)"	"Increased, Thyroid-stimulating hormone (TSH)"	Tissue
1024	"Increased, Hypertrophy and proliferation (follicular cell)"	"Increased, Hypertrophy and proliferation (follicular cell)"	Cellular
1025	"Increased, Hyperplasia (follicular cells)"	"Increased, Hyperplasia (follicular cells)"	Tissue
1026	"Increased Apoptosis, Adenomas/carcinomas (follicular cell)"	"Increased Apoptosis, Adenomas/carcinomas (follicular cell)"	Tissue
1027	", Learning and memory, impairment"	", Learning and memory, impairment"	
1028	"Activation of specific nuclear receptors, PPAR-gamma activation"	"Activation of specific nuclear receptors, PPAR-gamma activation"	Molecular
1029	"Increased, adipogenesis"	"Increased, adipogenesis"	Cellular
1030	"Increased,"	"Increased,"	
1031	"Increased, release of growth factors"	"Increased, release of growth factors"	
1032	"Increased, secretion of local growth factors"	"Increased, secretion of local growth factors"	Cellular
1033	"Increased, proliferation of mesenchymal cells"	"Increased, proliferation of mesenchymal cells"	Cellular
1034	"Increased, IGF-1 (mouse)"	"Increased, IGF-1 (mouse)"	Cellular
1035	"Increased, Firbrosarcoma"	"Increased, Firbrosarcoma"	Tissue
1036	"Increased, liposarcoma"	"Increased, liposarcoma"	Tissue
1037	"Increased, hemagiosarcoma"	"Increased, hemagiosarcoma"	Tissue
1038	"Activation, beta-2 adrenergic receptor"	"Activation, beta-2 adrenergic receptor"	Molecular
1039	"Increased activity, beta-2 adrenergic receptor"	"Increased activity, beta-2 adrenergic receptor"	Molecular
1040	"relaxation, smooth muscle"	"relaxation, smooth muscle"	Tissue
1041	"Proliferation, smooth muscle"	"Proliferation, smooth muscle"	
1042	"Proliferation/Clonal Expansion, smooth muscle"	"Proliferation/Clonal Expansion, smooth muscle"	Cellular
1043	"Hypertrophy/hyperplasia, smooth muscle"	"Hypertrophy/hyperplasia, smooth muscle"	Cellular
1044	"Promotion, mesovarian leiomyomas"	"Promotion, mesovarian leiomyomas"	Tissue
1045	"Decreased, Ovarian E2"	"Decreased, Ovarian E2"	Tissue
1046	"Suppression, Estrogen receptor (ER) activity"	"Suppression, Estrogen receptor (ER) activity"	Molecular
1047	"Increased, secretion of GnRH from hypothalamus"	"Increased, secretion of GnRH from hypothalamus"	Cellular
1048	"Increased, secretion of leutenizing hormone"	"Increased, secretion of leutenizing hormone"	
1049	"Increased, secrection of FSH from anterior pituitary"	"Increased, secrection of FSH from anterior pituitary"	Cellular
1050	"Increased, secretion of LH from anterior pituitary"	"Increased, secretion of LH from anterior pituitary"	Cellular
1051	"Hyperplasia, ovarian stromal cells"	"Hyperplasia, ovarian stromal cells"	Cellular
1052	"Hyperplasia, ovarian epithelium"	"Hyperplasia, ovarian epithelium"	Tissue
1053	"Promotion, ovarian adenomas"	"Promotion, ovarian adenomas"	Tissue
1054	"Promotion, ovarian granular cell tumors"	"Promotion, ovarian granular cell tumors"	Cellular
1055	"Decreased, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus"	"Decreased, Reduced estradiol in circulation decreases estrogen concentration at hypothalamu"	
1056	"Decrease, E2 blood concentrations at hypothalamus"	"Decrease, E2 blood concentrations at hypothalamus"	Tissue
1057	"Increased, PPAR-alpha activation"	"Increased, PPAR-alpha activation"	Molecular
1058	"Decreased, bile flow"	"Decreased, bile flow"	Organ
1059	"Increased, cholestasis"	"Increased, cholestasis"	Organ
1060	"Alteration, lipid metabolism"	"Alteration, lipid metabolism"	Cellular
1061	"prolonged, elevation of serun CCK"	"prolonged, elevation of serun CCK"	Tissue
1062	"Increased, Cellular proliferation / hyperplasia of acinar cells"	"Increased, Cellular proliferation / hyperplasia of acinar cells"	Cellular
1063	"Increased, Pancreatic acinar tumors"	"Increased, Pancreatic acinar tumors"	Organ
1064	"prepubertal increase, Estrogen receptor (ER) activity"	"prepubertal increase, Estrogen receptor (ER) activity"	Molecular
1065	"Activation, estrogen receptor alpha"	"Activation, estrogen receptor alpha"	Molecular
1066	"Promotion, SIX-1 postive basal-type progenitor cells"	"Promotion, SIX-1 postive basal-type progenitor cells"	Cellular
1067	"Proliferation/Clonal Expansion, aberrant basal cells"	"Proliferation/Clonal Expansion, aberrant basal cells"	Cellular
1068	"squamous metaplasia, aberrant basal cells"	"squamous metaplasia, aberrant basal cells"	Tissue
1069	"Increased, Hyperplasia (glandular epithelial cells of endometrium)"	"Increased, Hyperplasia (glandular epithelial cells of endometrium)"	Cellular
1070	"Increased, adenosquamous carcinomas of endometrium"	"Increased, adenosquamous carcinomas of endometrium"	Tissue
1071	"Decreased, GnRH pulsatility/release in hypothalamus"	"Decreased, GnRH pulsatility/release in hypothalamus"	Cellular
1072	"Decreased, LH Surge from anterior pituitary"	"Decreased, LH Surge from anterior pituitary"	Cellular
1073	"anovulation,"	"anovulation,"	
1074	"interruption, Ovulation"	"interruption, Ovulation"	Individual
1075	"prolonged, estrus"	"prolonged, estrus"	Individual
1076	"Increased, circulating estrogen levels"	"Increased, circulating estrogen levels"	Organ
1077	"Increased, prolactin exposure"	"Increased, prolactin exposure"	Tissue
1078	"Hyperplasia, Mammary gland"	"Hyperplasia, Mammary gland"	Tissue
1079	"Increased, Adenomas/carcinomas (mammary)"	"Increased, Adenomas/carcinomas (mammary)"	Tissue
1080	"Increased, latency period"	"Increased, latency period"	Individual
1081	"Increased, lactotroph hyperplasia and hypertrophy"	"Increased, lactotroph hyperplasia and hypertrophy"	Cellular
1082	"Increased, adenomas (pituitary)"	"Increased, adenomas (pituitary)"	Tissue
1083	"Decreased, Dopaminergic activity"	"Decreased, Dopaminergic activity"	Cellular
1084	"Increased, prolactin secretion"	"Increased, prolactin secretion"	Tissue
1085	"Increased, hyperplasia (mammary gland)"	"Increased, hyperplasia (mammary gland)"	Tissue
1086	"persistent, cytotoxicity (pleura or peritoneum)"	"persistent, cytotoxicity (pleura or peritoneum)"	Cellular
1087	"Increased, inflammation"	"Increased, inflammation"	Cellular
1088	"Increased, Oxidative Stress"	"Increased, Oxidative Stress"	Cellular
1089	"Increased, Cell Proliferation (mesothelium)"	"Increased, Cell Proliferation (mesothelium)"	Cellular
1090	"Increased, mesotheliomas"	"Increased, mesotheliomas"	Tissue
1091	"Physical and/or chemical interaction with cellular components,"	"Physical and/or chemical interaction with cellular components,"	
1092	"Pulmonary Fibrosis,"	"Pulmonary Fibrosis,"	
1093	"Decreased, Thyroxine (T4) in tissues"	"Decreased, Thyroxine (T4) in tissues"	Tissue
1094	", hyperuricemia"	", hyperuricemia"	
1095	"hyperuricemia,"	"hyperuricemia,"	
1096	"Increased, blood uric acid concentration"	"Increased, blood uric acid concentration"	Tissue
1097	"Occurrence, renal proximal tubular necrosis"	"Occurrence, renal proximal tubular necrosis"	Tissue
1098	"Increased, blood potassium concentration"	"Increased, blood potassium concentration"	Tissue
1099	"Increased, mortality 2"	"Increased, mortality 2"	
1100	"Occurrence, cardiac arrthymia"	"Occurrence, cardiac arrthymia"	
1101	"Altered, Amphibian metamorphosis"	"Altered, Amphibian metamorphosis"	Organ
1102	"Occurrence, tophi (urate) deposition"	"Occurrence, tophi (urate) deposition"	Tissue
1103	"Inhibition, Cyclooxygenase 1 activity"	"Inhibition, Cyclooxygenase 1 activity"	Molecular
1104	"Decreased, Prostaglandin F2alpha concentration, plasma"	"Decreased, Prostaglandin F2alpha concentration, plasma"	Tissue
1105	"Occurrence, renal ischemia"	"Occurrence, renal ischemia"	Tissue
1106	"Occurrence, cardiac arrhythmia"	"Occurrence, cardiac arrhythmia"	Organ
1107	"Weakened, Colony"	"Weakened, Colony"	Population
1108	"Abnormal, Role change within caste"	"Abnormal, Role change within caste"	Population
1109	"Increased, Deformed Wing Virus levels"	"Increased, Deformed Wing Virus levels"	Individual
1110	"Increased, Energetic demands and therefore metabolic stress"	"Increased, Energetic demands and therefore metabolic stress"	Individual
1111	"weaj,"	"weaj,"	
1112	"Occurrence, Oxidative Stress"	"Occurrence, Oxidative Stress"	
1113	"Unknown,"	"Unknown,"	
1114	"Unknown, MIE"	"Unknown, MIE"	Molecular
1115	"Increased, Reactive oxygen species"	"Increased, Reactive oxygen species"	Cellular
1116	"Decreased, Triiodothyronine (T3) in tissues"	"Decreased, Triiodothyronine (T3) in tissues"	Tissue
1117	"Irreversible inhibition of VKOR by binding at tyrosine 139,"	"Irreversible inhibition of VKOR by binding at tyrosine 139,"	
1118	"Irreversible inhibition of VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"	"Irreversible inhibition of VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin"	
1119	"Failure in gamma-glutamyl carboxylation of glutamine residues on clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)"	"Failure in gamma-glutamyl carboxylation of glutamine residues on clotting factors II, VII,"	
1120	"Under carboxylated clotting factors will not assemble on cell surfaces , Failure to form clot"	"Under carboxylated clotting factors will not assemble on cell surfaces , Failure to form cl"	
1121	"Hemorrhage , organ dysfunction, hypovolemic shock"	"Hemorrhage , organ dysfunction, hypovolemic shock"	
1122	"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis"	"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failur"	Tissue
1123	"Hemorrhage, organ dysfunction, hypovolemic shock, Impaired oxygen delivery to tissue"	"Hemorrhage, organ dysfunction, hypovolemic shock, Impaired oxygen delivery to tissue"	
1124	"Hemorrhage , Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"	"Hemorrhage , Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon diox"	
1125	"Impaired oxygen and nutrient delivery to tissue, impaired removal of carbon dioxide and other waste products, Hemorrhage, organ dysfunction and hypovolemic shock"	"Impaired oxygen and nutrient delivery to tissue, impaired removal of carbon dioxide and oth"	
1126	"Unresolved blood loss, Failure in vascular repair mechanisms"	"Unresolved blood loss, Failure in vascular repair mechanisms"	
1127	"Anemia, Impaired oxygen and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"	"Anemia, Impaired oxygen and nutrient delivery to tissue, impaired carbon dioxide and waste"	
1128	"Unresolved hemorrhage, Failure in vascular repair mechanisms"	"Unresolved hemorrhage, Failure in vascular repair mechanisms"	
1129	"Unresolved blood loss (hemorrhage), Failure in vascular repair mechanisms"	"Unresolved blood loss (hemorrhage), Failure in vascular repair mechanisms"	
1130	"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"	"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"	Organ
1131	"Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)"	"Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X, Under carbo"	Molecular
1132	"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"	"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tis"	Cellular
1133	"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"	"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"	Tissue
1134	"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"	"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle"	Molecular
1135	"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"	"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"	Tissue
1136	"Impaired recruitment , Population trajectory"	"Impaired recruitment , Population trajectory"	Population
1137	"Under carboxylation of osteocalcin, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"	"Under carboxylation of osteocalcin, Failure to cycle vitamin K epoxide to vitamin K to form"	
1138	"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"	"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"	Molecular
1139	"Increased, water retention in foot"	"Increased, water retention in foot"	Organ
1140	"Delayed, Sexual maturity"	"Delayed, Sexual maturity"	Individual
1141	"Decreased, Reproductive Success"	"Decreased, Reproductive Success"	Individual
1142	"Increased, valve movement"	"Increased, valve movement"	Tissue
1143	"Depletion, energy reserves"	"Depletion, energy reserves"	Individual
1144	"premature, spawning 1 1"	"premature, spawning 1"	
1145	"Decreased, gametogenesis"	"Decreased, gametogenesis"	
1146	"premature, Spawning"	"premature, Spawning"	Individual
1147	"increased or inappropriate, mantel display"	"increased or inappropriate, mantel display"	Individual
1148	"Anticoagulant rodenticide interferes with gamma-carboxyglutamate formation, Inhibition of protein synthesis in bone"	"Anticoagulant rodenticide interferes with gamma-carboxyglutamate formation, Inhibition of p"	
1149	"Calcium cannot bind to the hydroxyapatite matrix of bone, Osteocalcin and other bone proteins (periostin, MGP and periostin like factor) not formed"	"Calcium cannot bind to the hydroxyapatite matrix of bone, Osteocalcin and other bone protei"	
1150	"Uncarboxylated osteocalcin not incorporated into bone matrix, decreasing bone strength, Impaired function of osteocalcin and MGP"	"Uncarboxylated osteocalcin not incorporated into bone matrix, decreasing bone strength, Imp"	
1151	"Osteoporosis and vascular calcification, Bone deterioration"	"Osteoporosis and vascular calcification, Bone deterioration"	Individual
1152	"Inhibition, Iodotyrosine deiodinase (IYD)"	"Inhibition, Iodotyrosine deiodinase (IYD)"	Molecular
1153	"Inhibition, Deiodinase 3"	"Inhibition, Deiodinase 3"	Molecular
1154	"Increased, Triiodothyronine (T3) in tissues"	"Increased, Triiodothyronine (T3) in tissues"	Tissue
1155	"Inhibition, Pendrin"	"Inhibition, Pendrin"	Molecular
1156	"Inhibition, Dual oxidase"	"Inhibition, Dual oxidase"	Molecular
1157	"Activation, Hepatic nuclear receptor(s)"	"Activation, Hepatic nuclear receptor(s)"	Molecular
1158	"Increased, Hepatic thyroid hormone uptake/transport"	"Increased, Hepatic thyroid hormone uptake/transport"	Tissue
1159	"Increased, reuptake of 5-HT (5-hydroxytryptamine transporter; sodium-dependent serotonin transporter"	"Increased, reuptake of 5-HT (5-hydroxytryptamine transporter; sodium-dependent serotonin tr"	
1160	"Increased, mantel display"	"Increased, mantel display"	Individual
1161	"Increased, oocyte maturation"	"Increased, oocyte maturation"	Organ
1162	"Increased, cilia movement"	"Increased, cilia movement"	Cellular
1163	"Increased, Reproductive Success"	"Increased, Reproductive Success"	Individual
1164	"Increased, Population"	"Increased, Population"	Population
1165	"Vitamin K inhibition, gamma-carboxylation of glutamate to Gla residues reduced in bone proteins e.g., periostin"	"Vitamin K inhibition, gamma-carboxylation of glutamate to Gla residues reduced in bone prot"	
1166	"Increased, water pumping"	"Increased, water pumping"	Tissue
1167	"induced, parturition"	"induced, parturition"	Individual
1168	"Undercarboxylation of osteocalcin , Affects bone formation (osteoblast-osteoclast interaction, bone resorption) and glucose and lipid hoemostasis"	"Undercarboxylation of osteocalcin , Affects bone formation (osteoblast-osteoclast interacti"	
1169	"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"	"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment"	Molecular
1170	"modulation, Genes/proteins that regulate hepatocyte fate"	"modulation, Genes/proteins that regulate hepatocyte fate"	Cellular
1171	"Increase, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci"	"Increase, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci"	Cellular
1172	"Increase activation, Nuclear factor kappa B (NF-kB)"	"Increase activation, Nuclear factor kappa B (NF-kB)"	Molecular
1173	"Increase, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids"	"Increase, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids"	Molecular
1174	"Activation, NADPH Oxidase"	"Activation, NADPH Oxidase"	Molecular
1175	"Increase, Genes involved in fatty acid oxidation"	"Increase, Genes involved in fatty acid oxidation"	Cellular
1176	"Decreased, sodium conductance 2"	"Decreased, sodium conductance 2"	Cellular
1177	"Decreased, Ionotropic GABA receptor chloride channel conductance"	"Decreased, Ionotropic GABA receptor chloride channel conductance"	Cellular
1178	"Decreased, Chloride conductance"	"Decreased, Chloride conductance"	
1179	"Decreased, GABA release"	"Decreased, GABA release"	Cellular
1180	"Estrogen receptor activation,"	"Estrogen receptor activation,"	
1181	"Activation, Estrogen receptor"	"Activation, Estrogen receptor"	Molecular
1182	"Increase, Cell Proliferation (Epithelial Cells)"	"Increase, Cell Proliferation (Epithelial Cells)"	Cellular
1183	"Decreased, Apoptosis (Epithelial Cells)"	"Decreased, Apoptosis (Epithelial Cells)"	Cellular
1184	"Dysfunction, Mitochondrial Dynamics"	"Dysfunction, Mitochondrial Dynamics"	
1185	"Mitochondrial Dysfunction, N/A"	"Mitochondrial Dysfunction, N/A"	
1186	"N/A, Mitochondrial Dysfunction 2"	"N/A, Mitochondrial Dysfunction 2"	
1187	"Increased, ER binding to DNA (classical pathway)"	"Increased, ER binding to DNA (classical pathway)"	Molecular
1188	"Increased, ER binding to T.F. to DNA (non-classical pathway)"	"Increased, ER binding to T.F. to DNA (non-classical pathway)"	Molecular
1189	"Increased, Proliferation (Endothelial cells)"	"Increased, Proliferation (Endothelial cells)"	Cellular
1190	"Increased, Migration (Endothelial Cells)"	"Increased, Migration (Endothelial Cells)"	Cellular
1191	"Increased, Non-genomic signaling"	"Increased, Non-genomic signaling"	Cellular
1192	"Increased, Ductal Hyperplasia"	"Increased, Ductal Hyperplasia"	Tissue
1193	"N/A, Breast Cancer"	"N/A, Breast Cancer"	Individual
1194	"Increased, DNA Damage"	"Increased, DNA Damage"	Molecular
1195	"modulation, Extracellular Matrix Composition"	"modulation, Extracellular Matrix Composition"	Cellular
1196	"Increased, Invasion"	"Increased, Invasion"	Cellular
1197	"Activation, Fibroblasts"	"Activation, Fibroblasts"	Cellular
1198	"Activation, Macrophages"	"Activation, Macrophages"	Cellular
1199	"Binding of FK506 to FKBP12,"	"Binding of FK506 to FKBP12,"	
1200	"Binding of FK506 to FKBP12, Formation"	"Binding of FK506 to FKBP12, Formation"	
1201	"Formation, Binding of FK506 to FKBP12"	"Formation, Binding of FK506 to FKBP12"	Molecular
1202	"Activation, Hampered NFAT activation and following nuclear localization"	"Activation, Hampered NFAT activation and following nuclear localization"	Molecular
1203	"Suppression, Suppression of production of cytotoxic T-cells"	"Suppression, Suppression of production of cytotoxic T-cells"	Tissue
1204	"Suppression, Suppression of T-cell dependent antibody production"	"Suppression, Suppression of T-cell dependent antibody production"	Cellular
1205	"Activation, Juvenile hormone receptor"	"Activation, Juvenile hormone receptor"	Molecular
1206	"Induction, Doublesex1 gene"	"Induction, Doublesex1 gene"	Molecular
1207	"Induction, Male traits formation in embryos"	"Induction, Male traits formation in embryos"	
1208	"Increased, Male offspring"	"Increased, Male offspring"	Population
1209	"Induction, Male reproductive tract"	"Induction, Male reproductive tract"	Organ
1210	"Alteration, Food-web structures"	"Alteration, Food-web structures"	Population
1211	"Altered, food-web structures"	"Altered, food-web structures"	Population
1212	"Reduced, Neuronal synaptic inhibition"	"Reduced, Neuronal synaptic inhibition"	Cellular
1213	"Increased, Angiogenesis"	"Increased, Angiogenesis"	Cellular
1214	"Altered gene expression specific to CAR activation, Hepatocytes"	"Altered gene expression specific to CAR activation, Hepatocytes"	Cellular
1215	"TRPA1 activation, TRPA1 Receptor"	"TRPA1 activation, TRPA1 Receptor"	Molecular
1216	"Influx of Ca2+, Excitation of trigeminal nerves"	"Influx of Ca2+, Excitation of trigeminal nerves"	
1217	"Sensory airway irritation, Excitation of trigeminal nerves"	"Sensory airway irritation, Excitation of trigeminal nerves"	
1218	"Opening of calcium channel, Calcium influx"	"Opening of calcium channel, Calcium influx"	Cellular
1219	"Release of Substance P (SP), Substance P increase in circulation"	"Release of Substance P (SP), Substance P increase in circulation"	
1220	"Excitation, Neuron nerve ending excitation"	"Excitation, Neuron nerve ending excitation"	Cellular
1221	"Cough, Dyspnea, Sneezing, Acute respiratory effect"	"Cough, Dyspnea, Sneezing, Acute respiratory effect"	
1222	"SP (Substance P) release, Local increase of SP"	"SP (Substance P) release, Local increase of SP"	Cellular
1223	"Airway Hyper-responsiveness,Cough, Dyspnea, Trigeminal and/or vagal nerve excitation"	"Airway Hyper-responsiveness,Cough, Dyspnea, Trigeminal and/or vagal nerve excitation"	Tissue
1224	"Non-neuronal production of TNF, Epithelial irritation"	"Non-neuronal production of TNF, Epithelial irritation"	Individual
1225	"Leukocyte infiltration, Tissue irritation/inflammation"	"Leukocyte infiltration, Tissue irritation/inflammation"	Tissue
1226	"Chronic Cough, Respiratory irritability"	"Chronic Cough, Respiratory irritability"	Individual
1227	"TRPA1 activation, Chemical covalent binding to sulfhydyl group on TRPA1 receptor protein/NEK293 fibroblast cells"	"TRPA1 activation, Chemical covalent binding to sulfhydyl group on TRPA1 receptor protein/NE"	
1228	"TRPA1 activation, Classic receptor binding / HEK 293 cells (fibroclast), cho cells (ovary), noncovalently linkked)"	"TRPA1 activation, Classic receptor binding / HEK 293 cells (fibroclast), cho cells (ovary),"	
1229	"TRPA1 activation, Chemical covalent binding to sulfhydyl group on TRPA1 receptor protein/ HEK293 fibroblast cells"	"TRPA1 activation, Chemical covalent binding to sulfhydyl group on TRPA1 receptor protein/ H"	
1230	"TRPV1 activation, TRPV1"	"TRPV1 activation, TRPV1"	Molecular
1231	"Oxidization of biomolecules, Lipid bilayer and cellular proteins"	"Oxidization of biomolecules, Lipid bilayer and cellular proteins"	
1232	"Production of nerve growth factor ,"	"Production of nerve growth factor ,"	
1233	"Production, Nerve growth factor"	"Production, Nerve growth factor"	
1234	"Production of nerve growth factor , Epithelial irritation"	"Production of nerve growth factor , Epithelial irritation"	Tissue
1235	"Non-neuronal production of IL-8/CXCL1, Epithelial irritation"	"Non-neuronal production of IL-8/CXCL1, Epithelial irritation"	Tissue
1236	"Generation of novel epitopes , Antigen presentation"	"Generation of novel epitopes , Antigen presentation"	Cellular
1237	"Sensitization, Immune system"	"Sensitization, Immune system"	Individual
1238	"Lipid membranes, proteins, DNA, Oxidation of biomolecules"	"Lipid membranes, proteins, DNA, Oxidation of biomolecules"	Molecular
1239	"Altered, Gene Expression"	"Altered, Gene Expression"	Molecular
1240	"Altered, Protein Production"	"Altered, Protein Production"	Cellular
1241	"Increased, Motility"	"Increased, Motility"	Cellular
1242	"Increased, Second Messenger Production"	"Increased, Second Messenger Production"	Cellular
1243	"Altered, Ca2+-calmodulin activated signal transduction"	"Altered, Ca2+-calmodulin activated signal transduction"	Cellular
1244	"Mucus hypersecretion,"	"Mucus hypersecretion,"	
1245	"Mucus , Hypersecretion"	"Mucus , Hypersecretion"	
1246	"Lung function, Decrease"	"Lung function, Decrease"	
1247	"EGFR , PPAR-alpha activation"	"EGFR , PPAR-alpha activation"	
1248	"EGFR , Activation"	"EGFR , Activation"	
1249	"Oxidative Stress,"	"Oxidative Stress,"	
1250	"Decrease, Lung function"	"Decrease, Lung function"	Individual
1251	"Chronic, Mucus hypersecretion"	"Chronic, Mucus hypersecretion"	Tissue
1252	In utero exposure to DNA topoisomerase II “poisons”	In utero exposure to DNA topoisomerase II “poisons”	Molecular
1253	In utero MLL chromosomal translocation	MLL translocation	Cellular
1254	Infant leukaemia	IFL	Individual
1255	induced spawning	induced spawning	Individual
1256	increased mantel display	increased mantel display	Organ
1257	Induced parturition	Induced parturition	Individual
1258	Decompartmentalization	Decompartmentalization	Cellular
1259	narcosis	narcosis	Cellular
1260	Direct mitochondrial inhibition	Direct mitochondrial inhibition	Molecular
1261	Mitochondrial impairment	Mitochondrial impairment	Molecular
1262	Apoptosis	Apoptosis	Tissue
1263	Necrosis	Necrosis	Tissue
1264	"Induction, Nuclear receptor E75b gene"	"Induction, E75b gene"	Molecular
1265	"Suppression, Fushi tarazu factor-1 gene"	"Suppression, Ftz-f1 gene"	Molecular
1266	"Reduction, Release of circulating crustacean cardioactive peptide"	"Reduction, Release of circulating CCAP"	Tissue
1267	"Reduction, Ecdysis motoneuron bursts"	"Reduction, Ecdysis motoneuron bursts"	Tissue
1268	"Reduction, Excitatory postsynaptic potential"	"Reduction, Excitatory postsynaptic potential"	Tissue
1269	"Increase, COX-2 expression"	"Increase, COX-2 expression"	Molecular
1270	Inactivation of PPAR?	Inactivation of PPAR?	Molecular
1271	Activation of TGF-? signaling	Activation of TGF-? signaling	Cellular
1272	Differentiation of Myofibroblast	Differentiation of Myofibroblast	Cellular
1273	Expression of Collagen	Expression of Collagen	Cellular
1274	Production of ?-smooth muscle actin	Production of ?-smooth muscle actin	Cellular
1275	Collagen Deposition	Collagen Deposition	Tissue
1276	Lung fibrosis	Lung fibrosis	Organ
1277	Reproductive failure	Reproductive failure	Individual
1278	ROS formation	ROS formation	Molecular
1279	"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK"	"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK"	Cellular
1280	"Activation, HIF-1"	"Activation, HIF-1"	Cellular
1281	"Increased, DNA Damage-Repair"	"Increased, DNA Damage-Repair"	Cellular
1282	"Activation, JAK/STAT pathway"	"Activation, JAK/STAT pathway"	Cellular
1283	"Activation, TGF-beta pathway"	"Activation, TGF-beta pathway"	Cellular
1284	"Up Regulation, SREBF2"	"Up Regulation, SREBF2"	Cellular
1285	"Up Regulation, Unsaturated fatty acid"	"Up Regulation, Unsaturated fatty acid"	Cellular
1286	"Down Regulation, GSS and GSTs gene"	"Down Regulation, GSS and GSTs gene"	Cellular
1287	Glutathione synthesis	Glutathione synthesis	Cellular
1288	"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene"	"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene"	Cellular
1289	Perturbation of cholesterol	Perturbation of cholesterol	Cellular
1290	Glutathione homeostasis	Glutathione homeostasis	Cellular
1291	Hepatotoxicity	Hepatotoxicity	Cellular
1292	"Activation, JNK"	"Activation, JNK"	Cellular
1293	"Activation, FOXO"	"Activation, FOXO"	Cellular
1294	"Inhibition, Wnt pathway"	"Inhibition, Wnt pathway"	Cellular
1295	Defect of Embryogenesis	Defect of Embryogenesis	Tissue
